PDCD10 and cerebral cavernous malformation: Studies have demonstrated that atorvastatin (80 mg/kg/d) significantly reduces CCM lesion burden in PDCD10+/−Trp53−/−and PDCD10+/−Msh2−/−mice (Shenkar et al.